Cargando…

Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021

We compared PCR results from SARS-CoV-2-positive patients tested in the community in France from 14 June to 30 July 2021. In asymptomatic individuals, Cq values were significantly higher in fully vaccinated than non-fully vaccinated individuals (effect size: 1.7; 95% CI: 1–2.3; p < 10(−6)). In sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanquart, François, Abad, Clémence, Ambroise, Joëvin, Bernard, Mathieu, Cosentino, Gina, Giannoli, Jean-Marc, Débarre, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447828/ https://www.ncbi.nlm.nih.gov/pubmed/34533119 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.37.2100824

Ejemplares similares

Temporal, age, and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022
por: Blanquart, François, et al.
Publicado: (2023)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021
por: Alizon, Samuel, et al.
Publicado: (2021)

Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021
por: Suetens, Carl, et al.
Publicado: (2021)

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
por: Ito, Kimihito, et al.
Publicado: (2021)

Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
por: Shitrit, Pnina, et al.
Publicado: (2021)

Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023
por: Grapin, Mathilde, et al.
Publicado: (2023)

Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021
por: Molenkamp, Richard, et al.
Publicado: (2021)

Contributions of the EURO 2020 football championship events to a third wave of SARS-CoV-2 in Scotland, 11 June to 7 July 2021
por: Marsh, Kimberly, et al.
Publicado: (2021)

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22
por: Bosetti, Paolo, et al.
Publicado: (2022)

Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017
por: Calba, Clémentine, et al.
Publicado: (2017)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Autochthonous dengue in two Dutch tourists visiting Département Var, southern France, July 2020
por: Vermeulen, Tom D, et al.
Publicado: (2020)

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
por: Kahn, Fredrik, et al.
Publicado: (2022)

Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2021)

Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021
por: Mazur-Panasiuk, Natalia, et al.
Publicado: (2021)

Projecting the COVID-19 epidemic risk in France for the summer 2021
por: Mazzoli, Mattia, et al.
Publicado: (2021)

Travel-associated and autochthonous Zika virus infection in mainland France, 1 January to 15 July 2016
por: Septfons, A, et al.
Publicado: (2016)

Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022
por: Berçot, Béatrice, et al.
Publicado: (2022)

Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
por: Merad, Yanis, et al.
Publicado: (2022)

Measles outbreak linked to insufficient vaccination coverage in Nouvelle-Aquitaine Region, France, October 2017 to July 2018
por: Bernadou, Anne, et al.
Publicado: (2018)

Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019
por: Poncin, Thibaut, et al.
Publicado: (2019)

Novel vancomycin resistance gene cluster in Enterococcus faecium ST1486, Belgium, June 2021
por: Xavier, Basil Britto, et al.
Publicado: (2021)

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
por: Campbell, Finlay, et al.
Publicado: (2021)

Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022
por: Atari, Nofar, et al.
Publicado: (2022)

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
por: Shah, Syed Ahmar, et al.
Publicado: (2021)

Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022
por: Day, Michaela, et al.
Publicado: (2022)

A large-scale outbreak of hand, foot and mouth disease, France, as at 28 September 2021
por: Mirand, Audrey, et al.
Publicado: (2021)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
por: Kroidl, Inge, et al.
Publicado: (2021)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
por: Kliker, Limor, et al.
Publicado: (2022)

An early start of West Nile virus seasonal transmission: the added value of One Heath surveillance in detecting early circulation and triggering timely response in Italy, June to July 2018
por: Riccardo, Flavia, et al.
Publicado: (2018)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
por: Zuckerman, Neta, et al.
Publicado: (2021)

Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022
por: Coppi, Marco, et al.
Publicado: (2022)

Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021
por: Calba, Clémentine, et al.
Publicado: (2021)

Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021
por: Espenhain, Laura, et al.
Publicado: (2021)

Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017
por: Charre, Caroline, et al.
Publicado: (2017)

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
por: Di Domenico, Laura, et al.
Publicado: (2021)

Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
por: Giddings, Rebecca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umsaph048uvt8ri7oh6q80bp0q